trending Market Intelligence /marketintelligence/en/news-insights/trending/Nd1DlvLfNEd92Bgh4lTtUw2 content esgSubNav
In This List

Neuren Pharmaceuticals director to retire

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Neuren Pharmaceuticals director to retire

Neuren Pharmaceuticals Ltd. said Larry Glass would retire from the company's board, effective Dec. 31.

The company said Glass would continue to serve as the company's chief scientific officer.

Australia's Neuren Pharmaceuticals develops therapies for brain injury, neurodevelopment and neurodegenerative disorders.